Parkman Healthcare Partners’s KalVista Pharmaceuticals KALV Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$7.68M	Sell	679,063 -74,689	-10%	-$844K	0.88%	42
2025 Q1	$8.7M	Buy	+753,752	New	+$8.7M	1.03%	37